Crotaverrine

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 大环内酯类和类似物
• 英文名称: Crotaverrine
• 英文别名: (4E,11Z)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
• 化学式: C₁₉H₂₇NO₆
• 分子量: 365.4
• InChiKey: HPDHKHMHQGCNPE-LSMSNJBFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  26
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.63
• 拓扑面积：
  93.1
• 氢给体数：
  1
• 氢受体数：
  7

ADMET

毒理性

• 致癌性证据

没有关于人类的数据。动物致癌性的证据有限。总体评估：第3组：该物质对人类致癌性无法分类。

No data are available in humans. Limited evidence of carcinogenicity in animals. OVERALL EVALUATION: Group 3: The agent is not classifiable as to its carcinogenicity to humans.

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 致癌物分类

国际癌症研究机构致癌物：千里光碱

IARC Carcinogenic Agent:Senkirkine

来源:International Agency for Research on Cancer (IARC)

毒理性

• 致癌物分类

国际癌症研究机构（IARC）致癌物分类：第3组：无法归类其对人类致癌性

IARC Carcinogenic Classes:Group 3: Not classifiable as to its carcinogenicity to humans

来源:International Agency for Research on Cancer (IARC)

毒理性

• 致癌物分类

国际癌症研究机构专著：第31卷：（1983年）某些食品添加剂、饲料添加剂和天然存在物质

IARC Monographs:Volume 31: (1983) Some Food Additives, Feed Additives and Naturally Occurring Substances

来源:International Agency for Research on Cancer (IARC)

毒理性

• 解毒与急救

基本治疗：建立专利气道。如有必要，进行吸痰。观察呼吸不足的迹象，如有需要，协助通气。通过非循环呼吸面罩以10至15升/分钟的速度给予氧气。监测肺水肿，如有必要进行治疗……。监测休克，如有必要进行治疗……。预见并处理癫痫发作……。对于眼睛污染，立即用水冲洗眼睛。在运输过程中，用生理盐水连续冲洗每只眼睛……。不要使用催吐剂。对于摄入，如果患者能吞咽、有强烈的干呕反射且不流口水，则用水冲洗口腔，并给予5毫升/千克，最多200毫升的水进行稀释……。在去污后，用干燥的无菌敷料覆盖皮肤烧伤……。/毒药A和B/

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poison A and B/

来源:Hazardous Substances Data Bank (HSDB)

文献信息

• METHODS FOR IDENTIFYING ARTHROPOD REPELLENTS, AND COMPOUNDS AND COMPOSITIONS IDENTIFIED BY SUCH METHODS
  申请人：The Regents of the University of California

  公开号：EP3409115A2

  公开（公告）日：2018-12-05

  Provided herein are screening methods for identifying compounds for use as an arthropod repellent based on the masking or inhibition of the detection of the skin odor by a cpA neuron. Provided herein are also screening methods for identifying compounds for use as an arthropod attractant based on activation of the cpA neuron. Further provided are one or more compounds identified using the screening methods described herein, and compositions containing such compounds.

  本文提供了根据掩蔽或抑制 cpA 神经元对皮肤气味的检测来确定用作节肢动物驱避剂的化合物的筛选方法。本文还提供了根据 cpA 神经元的激活来鉴定用作节肢动物吸引剂的化合物的筛选方法。此外，还提供了使用本文所述筛选方法鉴定出的一种或多种化合物，以及含有此类化合物的组合物。
• PROCÉDÉ D'EXTRACTION DES ALCALOÏDES PYRROLIZIDINIQUES
  申请人：Robertet S.A.

  公开号：EP3922633A1

  公开（公告）日：2021-12-15

  L'invention se rapporte à un procédé d'extraction des alcaloïdes pyrrolizidiniques présents dans un extrait végétal d'intérêt, comprenant au moins une étape d'hydrodistillation ou de distillation dudit extrait.

  本发明涉及一种提取相关植物提取物中吡咯里西啶生物碱的工艺，该工艺至少包括一个对所述提取物进行水蒸馏或蒸馏的步骤。
• Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein
  申请人：TUFTS UNIVERSITY

  公开号：US10202441B2

  公开（公告）日：2019-02-12

  Methods, compositions and kits are provided for treating a subject exposed to or at risk for exposure to a disease agent using a pharmaceutical composition including at least one recombinant binding protein or a source of expression of the binding protein, wherein the binding protein neutralizes a disease agent that is a toxin, for example a Clostridium difficile toxin, a Shiga toxin, a ricin toxin, or an anthrax toxin.

  提供了使用包括至少一种重组结合蛋白或结合蛋白表达源的药物组合物治疗暴露于或有暴露于疾病病原体风险的受试者的方法、组合物和试剂盒，其中结合蛋白可中和属于毒素的疾病病原体，例如艰难梭菌毒素、志贺毒素、蓖麻毒素或炭疽毒素。
• Methods for identifying arthropod repellents and attractants, and compounds and compositions identified by such methods
  申请人：The Regents of the University of California

  公开号：US10768168B2

  公开（公告）日：2020-09-08

  Provided herein are screening methods for identifying compounds for use as an arthropod repellent based on the masking or inhibition of the detection of the skin odor by a cpA neuron. Provided herein are also screening methods for identifying compounds for use as an arthropod attractant based on activation of the cpA neuron. Further provided are one or more compounds identified using the screening methods described herein, and compositions containing such compounds.

  本文提供了根据掩蔽或抑制 cpA 神经元对皮肤气味的检测来确定用作节肢动物驱避剂的化合物的筛选方法。本文还提供了根据 cpA 神经元的激活来鉴定用作节肢动物吸引剂的化合物的筛选方法。此外，还提供了使用本文所述筛选方法鉴定出的一种或多种化合物，以及含有此类化合物的组合物。
• Methods and compositions with a recombinant neutralizing binding protein for treating toxin exposure
  申请人：Tufts University

  公开号：US20140294826A1

  公开（公告）日：2014-10-02

  Methods, compositions and kits are provided for treating a subject exposed to or at risk for exposure to a disease agent using a pharmaceutical composition including at least one recombinant binding protein or a source of expression of the binding protein, wherein the binding protein neutralizes at least one or a plurality of disease agents that are toxins, for example at least one of a ricin toxin, a Shiga toxin, or an anthrax toxin.